<?xml version='1.0' encoding='utf-8'?>
<document id="31218903"><sentence text="LC-MS/MS method for quantification of 3,4-dihydroxyphenylglycol, a norepinephrine metabolite in plasma and brain regions."><entity charOffset="38-63" id="DDI-PubMed.31218903.s1.e0" text="3,4-dihydroxyphenylglycol" /><entity charOffset="67-81" id="DDI-PubMed.31218903.s1.e1" text="norepinephrine" /><pair ddi="false" e1="DDI-PubMed.31218903.s1.e0" e2="DDI-PubMed.31218903.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31218903.s1.e0" e2="DDI-PubMed.31218903.s1.e1" /></sentence><sentence text="Aim: To evaluate suitability of the LC-MS/MS method to quantify 3,4-dihydroxyphenylglycol (DHPG) that is used as a biomarker for monoamine oxidase (MAO) inhibition"><entity charOffset="64-89" id="DDI-PubMed.31218903.s2.e0" text="3,4-dihydroxyphenylglycol" /><entity charOffset="91-95" id="DDI-PubMed.31218903.s2.e1" text="DHPG" /><entity charOffset="129-138" id="DDI-PubMed.31218903.s2.e2" text="monoamine" /><pair ddi="false" e1="DDI-PubMed.31218903.s2.e0" e2="DDI-PubMed.31218903.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31218903.s2.e0" e2="DDI-PubMed.31218903.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31218903.s2.e0" e2="DDI-PubMed.31218903.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31218903.s2.e1" e2="DDI-PubMed.31218903.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31218903.s2.e1" e2="DDI-PubMed.31218903.s2.e2" /></sentence><sentence text=" Methods: DHPG was extracted using alumina basic cartridges and quantified on a triple quadrupole mass spectrometer using negative electrospray ionization, without the use of derivatization reagents"><entity charOffset="35-42" id="DDI-PubMed.31218903.s3.e0" text="alumina" /><entity charOffset="10-16" id="DDI-PubMed.31218903.s3.e1" text="DHPG" /><pair ddi="false" e1="DDI-PubMed.31218903.s3.e1" e2="DDI-PubMed.31218903.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31218903.s3.e1" e2="DDI-PubMed.31218903.s3.e0" /></sentence><sentence text=" Results: Modulation of DHPG levels was observed following administration of selective and nonselective MAO inhibitors and results were in correlation with historical MAO inhibition potential of compounds"><entity charOffset="24-27" id="DDI-PubMed.31218903.s4.e0" text="DHPG" /></sentence><sentence text=" Conclusion: The proposed method is sensitive enough to measure plasma DHPG levels and DHPG can be used as a biomarker to assess MAO inhibition potential of new therapeutic agents"><entity charOffset="71-74" id="DDI-PubMed.31218903.s5.e0" text="DHPG" /><entity charOffset="87-90" id="DDI-PubMed.31218903.s5.e1" text="DHPG" /><pair ddi="false" e1="DDI-PubMed.31218903.s5.e0" e2="DDI-PubMed.31218903.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31218903.s5.e0" e2="DDI-PubMed.31218903.s5.e1" /></sentence><sentence text="" /></document>